Fundraising Fox

Carol Lynch

Investor

Advisor at Delin Ventures

Farnham, England, United Kingdom

About

Carol Lynch is Chair at uMed and holds board and advisory positions. She has held senior executive roles across the pharmaceutical sector in North America and Europe, with experience in start-up, turnaround, and growth-stage businesses. She holds a degree in Zoology from the University of Sheffield and a Diploma in Marketing from Kingston University.

Experience

  1. uMedChaircurrent2023 — present
  2. adthera bioBoard Membercurrent2023 — presentGreater London, England, United Kingdom
  3. WINGSforGrowthMember Board of Directorscurrent2023 — presentNew Jersey, United States
  4. Delin VenturesSenior Advisorcurrent2022 — presentGreater London, England, United Kingdom
  5. SandozChief Business Officer2021 — 2023Basel, Switzerland
  6. Sandoz Inc.President US, and Head North America2018 — 2020Princeton, New Jersey
  7. Sandoz, A Novartis DivisionGlobal Head Biopharmaceuticals2014 — 2018Munich
  8. Novartis PharmaHead, US New Product Commercialization2009 — 2014
  9. Novartis PharmaHead Strategic Marketing, Respiratory2008 — 2009

Education

  1. The University of Sheffield1985 — 1988

Skills & more

Market Access50Clinical Development22Pharmaceutical Sales50Sales Effectiveness30Oncology15Pharmaceutical Industry61

From Carol's professional profile.

Same school

Shared employers

Colleagues at Delin Ventures